Tafuito tipharco treatment for stomach pathology (3 blisters x 10 tablets)
Dosage form Box of 3 blisters x 10 tablets
Specifications Itopriide
Ingredient
| Composition information | Content |
| Itopriide | 50mg |
Uses
Indications
tafuito indicated treatment of stomach and intestines caused by chronic gastritis (abdominal distention, upper abdominal pain, anorexia, heartburn, nausea and vomiting).
Pharmacokology
Mechanism of action
Itoprid hydrochloride increases the release of acetylcholin (ACH) due to the antagonistic effect of 9 D2 dopamine receptors, and inhibits the decomposition of acetylcholin released through the superiority of acetylcholinesterase, leading to increased gastric motivation.
Increases stomach and intestinal motility
Itoprid hydrochloride inhibits vomit in dogs caused by apomorphin, this effect depends on the dose.
Dynamic pharmacokinetics 2>Serum concentration
Serum concentration and pharmacokinetics parameters in healthy adults, after a single dose of oral 50mg otoprid hydrochloride at hunger are specified in Table 1.
Table 1: Dynamic parameters
Dosage distribution Results obtained from animal experiments: When putting "c-itoprid hydrochloride at a dose of 5 mg/kg into the duodenum for rats, radioactive activity concentration in stomach muscles is about 2 times higher than blood levels. Milk excretion: When taking oral dose of 5 mg/kg C- Itoprid hydrochloride for rats, radioactive activity in milk compared to serum is 1.2 times higher in cmax, 2.6 times higher inauc, and 2.1 times higher in t metabolism and elimination At the single dose of 100mg ITOPRID HYDROCLORID for healthy adults (6 men) when hungry, the rate of excretion through water pepper within 24 hours after the highest drink is the form of N-Oxide [67.54% of the dose (89.41% of the secretion in urine)] and then the form of constant drug (4.14%), and the remaining substances are not significant. In experiments using Microsome indicating CYP or Flavin Monooxygenase (FMO), showing that FM01 and FMO3 are involved in creating N-Oxide main metabolites. However, there is no n -oxygenase activity of CYP1A2, -2A6, -2B6, -2C8, -2C9, 2C19, 2D6, 2E1, or 3A4. Other issues Serum protein bonding ratio: The ratio of serum protein bonds is 96% after using a single dose of oral 100 mg of iToprid hydrochloride for healthy people (6 men) when hungry. 50
Before taking Tafuito tipharco treatment for stomach pathology (3 blisters x 10 tablets)
How to use
tafuito tablets for oral, drink before meals.
Dosage
The usual oral dose for adults is 150mg of iToprid hydrochloride 3 capsules daily, divided 3 times, 1 tablet each time.
This dose may be reduced depending on the age and condition of each patient.
Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when using overdose?
What to do when you forget 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.
Side Effects
When using Tafuito often has unwanted effects (ADR).
SHOCK AND HIRTHDAY: SHOCK AND HIRTY RESPONSIBILITY may appear, and should monitor patients closely. If you see any signs of shock and hypersensitivity reactions, such as hypotension, shortness of breath, laryngeal edema, urticaria, pale and sweating ..., should stop immediately and take appropriate treatments.
Disorders of liver and jaundice: liver and jaundice disorders along with AST (GOT), ALT (GPT) and Y-AGP ... may appear and patients should be closely monitored. If the above abnormal symptoms are detected, they should stop immediately and have appropriate treatments.
Common
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
contraindicated
tafuito contraindicated in the following cases:
Caution when using
should note when used because this drug increases the activity of acetylcholin.
Should not be used for a long time when there is no improvement in the symptoms of the stomach - intestines.
Because the physiological function in the elderly decreases, adverse reactions are more likely to occur. Therefore, elderly patients who use this drug should be carefully monitored, if any adverse reactions appear, should use appropriate management measures, such as reducing dose or stopping the drug.
The safety of the drug in children has not been determined.
Using drugs in pregnant and lactating women
This drug should only be used in pregnant women, or in women can be pregnant only when the desired benefits of therapy are greater than the risks may be encountered (the safety of this product in pregnant women has not been identified).
The effect of drugs on driving and operating machinery
drugs that do not cause headaches, dizziness should be used for drivers and machinery operation.
Drug interaction
should note when using a combination of Toprid hydrochloride with anti -antacids: Tiquizium Bromide, Scopolamine Butyl Bromide, TimePidium Bromide, ...
Symptoms: can reduce the effect of increasing stomach and intestinal motility of Itoprid (cholinergic effect).
Mechanism: The inhibitory effect of anti -cholinergic drugs may have pharmacological effects against the effect of itoPrid.
Storage
Leave a cool place, avoid light, temperature below 30⁰C.
To be out of reach of children.
Other drugs
- DICLOPRAM 75 MG / 20 MG MODIFIED RELEASE HARD CAPSULES
- DF 118 FORTE 40MG
- MIGRIL TABLETS
- PANADOL EXTRA TABLETS
- PANADOL ADVANCE 500 MG TABLETS
- ZYDOL 50MG CAPSULES
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions